ZCMD, ABCL, VOR, IXHL, OVID, BFRG Rally After Hours On Clinical Momentum And Recent Updates - Nasdaq
4 hours ago • Google News
Incannex Healthcare Ltd ADR (IXHL)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 55.74M
P/E Ratio
0.00
Revenue (TTM)
$ 86K
Volume
0
52W High
$ 3.12
52W Low
$ 0.08
Dividend Yield
0.00%
Beta
2.71
Technicals
50-Day MA
0.6034
200-Day MA
0.8395
52 Week High
3.12
52 Week Low
0.08
About IXHL
Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research, development, manufacture, sale, and distribution of psychedelic medicines and therapies for patients with.
Employees
9
Headquarters
Sydney, NSW
CEO
Mr. Joel Bradley Latham